Book on patient stories on MDR-TB launched

20 July 2016 | News | By BioSpectrum Bureau

Book on patient stories on MDR-TB launched

(Photo Courtesy: www.authormedia.com)

(Photo Courtesy: www.authormedia.com)

Lilly MDR-TB partnership announced the release of a first-of-its-kind compilation of patient stories with insights on the disease burden and health implications of TB in India.

The book is authored by Mr Chapal Mehra, a well-known TB activist and provides a platform for people to share the stories of their struggle against the disease.

For many years, tuberculosis, and more recently MDR-TB, have imposed a significant physical, emotional and economic burden on patients, their families and the society.

As policies are designed to prevent and treat the disease, it becomes crucial to understand the needs, challenges and experiences of TB patients in the country.

The patient case book describes the grit and determination that the battle against TB requires of patients, particularly those who suffer from MDR-TB.

 

Written from the perspective of a patient, the book seeks to break common stereotypes and misconceptions surrounding the disease.

These stories successfully capture the sense of struggle and triumph underlying every survivor's story in their battle against the disease.

Speaking about the book, Mr Chapal Mehra said, "I am grateful that my humble attempt to throw more light on the struggles of TB patients will have the chance to reach more people. It is my hope that this book will empower more TB patients to speak out, have their voices heard and increase awareness that TB is a curable disease."

The most commonly shared patient experience is the need for guidance and support to adhere to the full treatment protocol.

The lack of a supportive environment as well as other physical and economic challenges often force patients to abandon treatment.

This leads to patients developing drug resistant TB. Other issues that contribute to developing MDR-TB are delayed diagnosis and treatment, severe side-effects and societal stigma.

Mr Anant Garg, Director, Corporate Affairs, Pricing, Reimbursement & Access, Eli Lilly, said, "We realized that there are not many platforms where people who have gone through this difficult journey can share personal insights and articulate the real challenges and issues that they face. This book is our little attempt in that direction and will hopefully help all the stakeholders relate better to those who have been impacted, and reflect on how to contribute in our own capacity to make life better for them."

The book covers the multiple social, economic and cultural determinants that come into play in tackling TB and illustrate how awareness, empowerment, family support and social stigma are possibly the most decisive factors in determining a TB patient's ability to fight this disease.

The book will be distributed among state TB officials, civil society organizations and partners working in the space of tuberculosis.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account